Breast Implant Illness Sufferers Hope for New Treatment
· business
A New Frontier for Breast Implant Illness Sufferers?
The emergence of 3D-printed breast scaffolds has sparked hope for women suffering from breast implant illness. These innovative devices, currently being trialed by Professor Anand Deva and his team at Macquarie University, have the potential to revolutionize the lives of thousands of Australian women affected by the condition.
Breast implant complications are a significant problem in Australia, with many women forced to undergo explant surgery only to be left with significant defects and scarring. The psychological toll is just as damaging, with women reporting symptoms such as pleurisy, migraines, fatigue, and body rashes.
The catalyst for this innovation was an email from PhD student Mohit Chayya to Professor Deva around 15 years ago. At the time, Deva’s clinic was inundated with women seeking treatment for breast implant complications. It’s testament to the dedication of researchers like Deva that they took notice of Chayya’s idea and pursued it.
The 3D-printed scaffold is made from polycaprolactone, a polymer used in absorbable sutures for decades. It’s designed to be porous, allowing fat cells to grow and multiply along its surface, eventually filling the space left by the implant. As the body absorbs the scaffold over two to three years, it leaves behind nothing but tissue.
The results from the trial are promising, with participants retaining 83% of their breast volume since surgery and no serious adverse events reported. Reconstructive surgeon Professor Owen Ung has performed 19 breast augmentations using the BellaSeno scaffold on women who had silicone implants as part of a phase 1 safety trial.
For women struggling to come to terms with the aftermath of breast implant illness, the prospect of regaining their natural tissue and avoiding further surgery is a significant development. While some may still require more volume than the scaffolds can provide, Dr. Tony Connell notes that the potential is undeniable: “Imagine if I could say to women: ‘we could take our implant out and safely put in a bio scaffold and your own fat’. It’s a very promising thing.”
The implications of this technology extend beyond the medical community. It highlights the growing recognition that innovation must be patient-centered, not just focused on technological advancements for their sake. The willingness of researchers like Chayya and Deva to listen to women’s stories and prioritize their needs has led to a development that could change lives.
As this technology continues to evolve, it will be crucial to ensure equitable access, particularly in regions with limited resources. The medical community must also grapple with the question of whether these scaffolds can be adapted for use in other areas, such as reconstructive surgery after mastectomies.
For now, the hope and promise embodied by this innovation offer a beacon of light to women struggling with breast implant illness. It’s a reminder that even in the face of adversity, medical breakthroughs can arise from unexpected places – and it’s up to us to seize them.
Reader Views
- DHDr. Helen V. · economist
While the 3D-printed breast scaffolds offer a promising solution for women struggling with breast implant illness, we mustn't overlook the economic implications of this innovation. The production costs of these scaffolds are likely to be prohibitively expensive for many women who have already undergone multiple surgeries and procedures. Will insurance coverage be expanded to include this new treatment, or will it fall under a "cosmetic" umbrella? Without clear answers on affordability and accessibility, this breakthrough may only exacerbate existing healthcare disparities.
- TNThe Newsroom Desk · editorial
While the 3D-printed breast scaffold trial shows promising results, we need to consider the long-term implications of relying on synthetic materials in medical devices. Polycaprolactone may be widely used in sutures, but its degradation rate and potential for interactions with surrounding tissue are still unknown variables. It's also unclear how these scaffolds will behave in different body types or under various lifestyle conditions. Researchers must continue to scrutinize the biocompatibility of these devices before they can be hailed as a revolutionary solution.
- MTMarcus T. · small-business owner
While it's heartening to see researchers exploring new treatments for breast implant illness, we can't lose sight of the bigger picture here: the majority of women affected by this condition are still waiting for proper regulation and accountability from manufacturers. The BellaSeno scaffold is a step in the right direction, but let's not forget that it's ultimately just a Band-Aid solution for a problem that's been years in the making. We need to see systemic changes, not just individual innovations, if we're going to truly support women who've been left scarred – both physically and emotionally – by breast implant complications.